Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.34 |
| ▸ | NOS2 | P35228 | 2/20 | 0.34 |
| ▸ | SRC | P12931 | 2/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20110472 | 0.78 | L3MBTL1 (0.50) | CYP2A6CYP1A2ALDH1A1CD44HTR7 | |
| SCHEMBL12621112 | 0.76 | — | — | |
| SCHEMBL4021982 | 0.76 | ACHE (0.57) | CYP2A6CYP1A2ALDH1A1CD44TRPA1 | |
| SCHEMBL12200494 | 0.74 | CYP2A6 (0.50) | CYP2A6CYP1A2ALDH1A1TSHRACHE | |
| SCHEMBL2508698 | 0.74 | HSP90AA1 (0.44) | CYP2A6CYP1A2ALDH1A1CD44HTR7 | |
| SCHEMBL20072679 | 0.73 | C1R (0.34) | CYP2A6CYP1A2ALDH1A1CD44HTR7 | |
| SCHEMBL15855019 | 0.73 | LMNA (0.37) | CYP2A6CYP1A2ALDH1A1CD44TRPA1 | |
| SCHEMBL12621111 | 0.73 | — | — | |
| SCHEMBL17672254 | 0.72 | ALDH1A1 (0.46) | CYP2A6CYP1A2ALDH1A1CD44TRPA1 | |
| SCHEMBL13312931 | 0.71 | L3MBTL1 (0.48) | CYP2A6CYP1A2ALDH1A1SRCDHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732598-B2 | Triazine-based compound, method of making the same, and an organic light-emitting device including the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-06-08 | — | — | US | disclosed |
| US-20070015007-A1 | Triazine-based compound, method of making the same, and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015007-A1 | Triazine-based compound, method of making the same, and an organic light-emitting device including the same | TPD52L2, TYR, CRY1 | CYP2A6 610/4885CYP1A2 107/4885ALDH1A1 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.